TI
Trigran Investments’s Anika Therapeutics ANIK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.5M | Sell |
2,036,511
-5,342
| -0.3% | -$56.5K | 3.74% | 13 |
|
|
2025
Q1 | $30.7M | Buy |
2,041,853
+20,075
| +1% | +$302K | 4.52% | 12 |
|
|
2024
Q4 | $33.3M | Sell |
2,021,778
-102,682
| -5% | -$1.69M | 3.83% | 13 |
|
|
2024
Q3 | $52.5M | Sell |
2,124,460
-11,772
| -0.6% | -$291K | 5.74% | 8 |
|
|
2024
Q2 | $54.1M | Buy |
2,136,232
+63,808
| +3% | +$1.62M | 5.66% | 8 |
|
|
2024
Q1 | $52.6M | Sell |
2,072,424
-66,630
| -3% | -$1.69M | 5.1% | 9 |
|
|
2023
Q4 | $48.5M | Sell |
2,139,054
-77,965
| -4% | -$1.77M | 4.67% | 9 |
|
|
2023
Q3 | $41.3M | Buy |
2,217,019
+410,390
| +23% | +$7.65M | 4.4% | 11 |
|
|
2023
Q2 | $46.9M | Buy |
1,806,629
+208,015
| +13% | +$5.4M | 4.53% | 10 |
|
|
2023
Q1 | $45.9M | Buy |
1,598,614
+34,073
| +2% | +$979K | 4.43% | 11 |
|
|
2022
Q4 | $46.3M | Buy |
1,564,541
+72,449
| +5% | +$2.14M | 4.64% | 11 |
|
|
2022
Q3 | $35.5M | Buy |
1,492,092
+337,909
| +29% | +$8.04M | 4.08% | 12 |
|
|
2022
Q2 | $25.8M | Buy |
1,154,183
+199,384
| +21% | +$4.45M | 3% | 14 |
|
|
2022
Q1 | $24M | Buy |
954,799
+362,611
| +61% | +$9.11M | 2.43% | 17 |
|
|
2021
Q4 | $21.2M | Buy |
592,188
+165,595
| +39% | +$5.93M | 2.03% | 17 |
|
|
2021
Q3 | $18.2M | Buy |
426,593
+242,240
| +131% | +$10.3M | 2% | 16 |
|
|
2021
Q2 | $7.98M | Buy |
+184,353
| New | +$7.98M | 0.88% | 16 |
|